Moreover, co‐immunoprecipitation assay demonstrated that TSP50 can inhibit the binding of the G6PD protein to acetylase KAT9 while promoting its binding to deacetylase SIRT2 in hepatoma cells (Figure 3G‐I) (Figure S2G‐I). This evidence concerns the gene PRSS50 and hepatocellular carcinoma.